Bookmark! (press Ctrl+D)

Todos Medical Ltd (OTCQB:TOMDF) CEO Gerald Commissiong tells it has signed an agreement with Aditx Therapeutics Inc (NASDAQ:ADTX), through which it has secured the rights to distribute Aditx’s immune-related AditxtScore COVID-19 scoring system, with planned availability in January 2021.

Commissiong says Aditx is focused on the immune space as it related to the coronavirus, and with the vaccine rolling out, Todos wanted to be on the frontlines to be able to help its clients manage immune responses to the virus snd whether patients should be getting the vaccine.

source

LEAVE A REPLY

Please enter your comment!
Please enter your name here